Suppr超能文献

新型 2-氨基-N-苯乙酰胺 Slack 钾通道抑制剂的构效关系研究。

Structure-activity relationship studies in a new series of 2-amino-N-phenylacetamide inhibitors of Slack potassium channels.

机构信息

Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, USA; Graduate School of Biomedical Sciences, University of North Texas Health Science Center, Fort Worth, TX, USA.

Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, USA.

出版信息

Bioorg Med Chem Lett. 2022 Nov 15;76:129013. doi: 10.1016/j.bmcl.2022.129013. Epub 2022 Sep 29.

Abstract

In this Letter we describe structure-activity relationship (SAR) studies conducted in five distinct regions of a new 2-amino-N-phenylacetamides series of Slack potassium channel inhibitors exemplified by recently disclosed high-throughput screening (HTS) hit VU0606170 (4). New analogs were screened in a thallium (Tl) flux assay in HEK-293 cells stably expressing wild-type human (WT) Slack. Selected analogs were screened in Tl flux versus A934T Slack and other Slo family members Slick and Maxi-K and evaluated in whole-cell electrophysiology (EP) assays using an automated patch clamp system. Results revealed the series to have flat SAR with significant structural modifications resulting in a loss of Slack activity. More minor changes led to compounds with Slack activity and Slo family selectivity similar to the HTS hit.

摘要

在这封信中,我们描述了对新型 2-氨基-N-苯乙酰胺 Slack 钾通道抑制剂系列中五个不同区域的结构-活性关系 (SAR) 研究,该抑制剂以最近披露的高通量筛选 (HTS) 命中物 VU0606170(4)为代表。新的类似物在稳定表达野生型人类 (WT) Slack 的 HEK-293 细胞中的铊 (Tl) 通量测定中进行筛选。选择的类似物在 Tl 通量与 A934T Slack 和其他 Slo 家族成员 Slick 和 Maxi-K 的通量中进行筛选,并使用自动化膜片钳系统在全细胞电生理学 (EP) 测定中进行评估。结果表明,该系列具有平坦的 SAR,显著的结构修饰导致 Slack 活性丧失。较小的变化导致具有 Slack 活性和 Slo 家族选择性的化合物与 HTS 命中物相似。

相似文献

1
Structure-activity relationship studies in a new series of 2-amino-N-phenylacetamide inhibitors of Slack potassium channels.
Bioorg Med Chem Lett. 2022 Nov 15;76:129013. doi: 10.1016/j.bmcl.2022.129013. Epub 2022 Sep 29.
4
Differential distribution of the sodium-activated potassium channels slick and slack in mouse brain.
J Comp Neurol. 2016 Jul 1;524(10):2093-116. doi: 10.1002/cne.23934. Epub 2015 Dec 15.
5
VU0606170, a Selective Slack Channels Inhibitor, Decreases Calcium Oscillations in Cultured Cortical Neurons.
ACS Chem Neurosci. 2020 Nov 4;11(21):3658-3671. doi: 10.1021/acschemneuro.0c00583. Epub 2020 Oct 14.
6
The antipsychotic drug loxapine is an opener of the sodium-activated potassium channel slack (Slo2.2).
J Pharmacol Exp Ther. 2012 Mar;340(3):706-15. doi: 10.1124/jpet.111.184622. Epub 2011 Dec 13.
7
Cell volume changes regulate slick (Slo2.1), but not slack (Slo2.2) K+ channels.
PLoS One. 2014 Oct 27;9(10):e110833. doi: 10.1371/journal.pone.0110833. eCollection 2014.
8
Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies.
Pharm Pat Anal. 2022 Mar;11(2):45-56. doi: 10.4155/ppa-2022-0002. Epub 2022 Apr 4.
10
PIP₂ modulation of Slick and Slack K⁺ channels.
Biochem Biophys Res Commun. 2012 Jul 27;424(2):208-13. doi: 10.1016/j.bbrc.2012.06.038. Epub 2012 Jun 21.

引用本文的文献

2
KCNT1 Channel Blockers: A Medicinal Chemistry Perspective.
Molecules. 2024 Jun 20;29(12):2940. doi: 10.3390/molecules29122940.
4
Interaction Between HCN and Slack Channels Regulates mPFC Pyramidal Cell Excitability in Working Memory Circuits.
Mol Neurobiol. 2024 Apr;61(4):2430-2445. doi: 10.1007/s12035-023-03719-8. Epub 2023 Oct 27.

本文引用的文献

1
Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies.
Pharm Pat Anal. 2022 Mar;11(2):45-56. doi: 10.4155/ppa-2022-0002. Epub 2022 Apr 4.
2
Discovery of the First Orally Available, Selective K1.1 Inhibitor: and Activity of an Oxadiazole Series.
ACS Med Chem Lett. 2021 Mar 9;12(4):593-602. doi: 10.1021/acsmedchemlett.0c00675. eCollection 2021 Apr 8.
3
VU0606170, a Selective Slack Channels Inhibitor, Decreases Calcium Oscillations in Cultured Cortical Neurons.
ACS Chem Neurosci. 2020 Nov 4;11(21):3658-3671. doi: 10.1021/acschemneuro.0c00583. Epub 2020 Oct 14.
4
Structure-Based Identification and Characterization of Inhibitors of the Epilepsy-Associated K1.1 (KCNT1) Potassium Channel.
iScience. 2020 May 22;23(5):101100. doi: 10.1016/j.isci.2020.101100. Epub 2020 Apr 25.
5
KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases.
Epilepsia. 2020 Apr;61(4):679-692. doi: 10.1111/epi.16480. Epub 2020 Mar 13.
7
Epilepsy with migrating focal seizures: KCNT1 mutation hotspots and phenotype variability.
Neurol Genet. 2019 Oct 25;5(6):e363. doi: 10.1212/NXG.0000000000000363. eCollection 2019 Dec.
8
Neonatal Developmental and Epileptic Encephalopathies.
Semin Pediatr Neurol. 2019 Dec;32:100770. doi: 10.1016/j.spen.2019.08.006. Epub 2019 Sep 11.
9
Concurrent Quinidine and Phenobarbital in the Treatment of a Patient with 2 Mutations.
Curr Ther Res Clin Exp. 2019 Feb 28;90:106-108. doi: 10.1016/j.curtheres.2019.02.002. eCollection 2019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验